BIOMAT Database Logo BIOMAT Database Logo

Myasthenia gravis, corticosteroids and osteoporosis prophylaxis. 2001

G D Smith, and D L Stevens, and G N Fuller

UI MeSH Term Description Entries
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D010024 Osteoporosis Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis. Age-Related Osteoporosis,Bone Loss, Age-Related,Osteoporosis, Age-Related,Osteoporosis, Post-Traumatic,Osteoporosis, Senile,Senile Osteoporosis,Osteoporosis, Involutional,Age Related Osteoporosis,Age-Related Bone Loss,Age-Related Bone Losses,Age-Related Osteoporoses,Bone Loss, Age Related,Bone Losses, Age-Related,Osteoporoses,Osteoporoses, Age-Related,Osteoporoses, Senile,Osteoporosis, Age Related,Osteoporosis, Post Traumatic,Post-Traumatic Osteoporoses,Post-Traumatic Osteoporosis,Senile Osteoporoses
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000305 Adrenal Cortex Hormones HORMONES produced by the ADRENAL CORTEX, including both steroid and peptide hormones. The major hormones produced are HYDROCORTISONE and ALDOSTERONE. Adrenal Cortex Hormone,Corticoid,Corticoids,Corticosteroid,Corticosteroids,Cortex Hormone, Adrenal,Hormone, Adrenal Cortex,Hormones, Adrenal Cortex
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D019983 Guideline Adherence Conformity in fulfilling or following official, recognized, or institutional requirements, guidelines, recommendations, protocols, pathways, or other standards. Institutional Adherence,Policy Compliance,Protocol Compliance,Adherence, Guideline,Adherence, Institutional,Compliance, Policy,Compliance, Protocol

Related Publications

G D Smith, and D L Stevens, and G N Fuller
Myasthenia gravis, corticosteroids, anticholinesterases.
January 1976, Annals of the New York Academy of Sciences,
G D Smith, and D L Stevens, and G N Fuller
Corticosteroids for myasthenia gravis.
April 2005, The Cochrane database of systematic reviews,
G D Smith, and D L Stevens, and G N Fuller
[Treatment of myasthenia gravis with corticosteroids].
January 1978, Neurologija,
G D Smith, and D L Stevens, and G N Fuller
Peribulbar Corticosteroids for Ocular Myasthenia Gravis.
April 2024, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society,
G D Smith, and D L Stevens, and G N Fuller
Osteoporosis prevention in myasthenia gravis: a reminder.
May 2001, Acta neurologica Scandinavica,
G D Smith, and D L Stevens, and G N Fuller
The use of ACTH and corticosteroids in myasthenia gravis.
September 1971, Annals of the New York Academy of Sciences,
G D Smith, and D L Stevens, and G N Fuller
Beneficial effects of corticosteroids on ocular myasthenia gravis.
August 1996, Archives of neurology,
G D Smith, and D L Stevens, and G N Fuller
Long-term administration of corticosteroids in myasthenia gravis.
August 1976, Neurology,
G D Smith, and D L Stevens, and G N Fuller
[Myasthenia gravis: treatment with massive doses of corticosteroids and thymectomy].
July 1978, Revista clinica espanola,
G D Smith, and D L Stevens, and G N Fuller
Oral corticosteroids in the treatment of ocular myasthenia gravis.
August 1974, Neurology,
Copied contents to your clipboard!